Reviticell Holdings
Jacksonville, US · Founded 2011 · Delaware corporation
Founders & leadership
SF
Sue FrittsExecutive
JD
John D. Murray, MDExecutive
GG
Gregory G. BendisExecutive
LF
Leslie FrillingExecutive
GG
Gary GranfieldNamed on SEC filing
Board
CG
Christine GranfieldBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2011
▶$1.6MraisedJan 2016 · 33 investors · BiotechnologyRule 506(c)
▶$1.6MraisedJan 2016 · 33 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Sue FrittsExecutive Officer, Director
- John D. Murray, MDExecutive Officer
- Gregory G. BendisExecutive Officer, Director, Promoter
- Gary GranfieldExecutive Officer, Director
- Leslie FrillingExecutive Officer, Director
- Christine GranfieldDirector
- Offering amount
- $5.6M
- Amount sold
- $1.6M
- Proceeds to insiders
- $455K
- First sale
- Jan 2011
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Reviticell Holdings raised?
- Reviticell Holdings has disclosed $1.6M raised across 1 round.
- Where is Reviticell Holdings headquartered?
- Reviticell Holdings is headquartered in Jacksonville, US.